Actinogen Medical Limited

Informe acción ASX:ACW

Capitalización de mercado: AU$74.5m

Actinogen Medical Dirección

Dirección controles de criterios 3/4

El CEO de Actinogen Medical's es Steve Gourlay , nombrado en Mar 2021, tiene una permanencia de 3.08 años. compensación anual total es A$656.89K, compuesta por 60.2% salario y 39.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 3.94% de las acciones de la empresa, por valor de A$2.75M. La antigüedad media del equipo directivo y de la junta directiva es de 2.2 años y 6.3 años, respectivamente.

Información clave

Steve Gourlay

Chief Executive Officer (CEO)

AU$656.9k

Compensación total

Porcentaje del salario del CEO60.2%
Permanencia del CEO3.1yrs
Participación del CEO3.9%
Permanencia media de la dirección2.2yrs
Promedio de permanencia en la Junta Directiva6.3yrs

Actualizaciones recientes de la dirección

Recent updates

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Nov 16
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Aug 02
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

We Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growth

Apr 12
We Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growth

We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely

Nov 28
We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Aug 09
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Apr 07
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

We're Not Worried About Actinogen Medical's (ASX:ACW) Cash Burn

Oct 24
We're Not Worried About Actinogen Medical's (ASX:ACW) Cash Burn

Actinogen Medical (ASX:ACW) Is In A Strong Position To Grow Its Business

Jul 11
Actinogen Medical (ASX:ACW) Is In A Strong Position To Grow Its Business

We're Interested To See How Actinogen Medical (ASX:ACW) Uses Its Cash Hoard To Grow

Mar 27
We're Interested To See How Actinogen Medical (ASX:ACW) Uses Its Cash Hoard To Grow

How Does Actinogen Medical's (ASX:ACW) CEO Pay Compare With Company Performance?

Jan 07
How Does Actinogen Medical's (ASX:ACW) CEO Pay Compare With Company Performance?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Steve Gourlay en comparación con los beneficios de Actinogen Medical?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2023n/an/a

-AU$15m

Sep 30 2023n/an/a

-AU$13m

Jun 30 2023AU$657kAU$396k

-AU$11m

Mar 31 2023n/an/a

-AU$11m

Dec 31 2022n/an/a

-AU$11m

Sep 30 2022n/an/a

-AU$10m

Jun 30 2022AU$955kAU$376k

-AU$9m

Mar 31 2022n/an/a

-AU$8m

Dec 31 2021n/an/a

-AU$7m

Sep 30 2021n/an/a

-AU$6m

Jun 30 2021AU$271kAU$112k

-AU$4m

Compensación vs. Mercado: La compensación total de Steve($USD423.66K) está por encima de la media de empresas de tamaño similar en el mercado Australian ($USD289.12K).

Compensación vs. Ingresos: La compensación de Steve ha sido consistente con los resultados de la empresa en el último año.

CEO

Steve Gourlay (63 yo)

3.1yrs

Permanencia

AU$656,888

Compensación

Dr. Steven G. Gourlay, also known as Steve, MBBS (M.D.), Ph D., FRACP, M.B.A., serves as Chief Executive Officer at Actinogen Medical Limited since March 15, 2021 and as its Managing Director and Director...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Steven Gourlay
MD, CEO & Director3.1yrsAU$656.89k3.94%
A$ 2.9m
Dana Hilt
Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board1.2yrsAU$478.29ksin datos
Paul Rolan
Head of Clinical Pharmacology & Lead Physician and Depression2.2yrsAU$191.66ksin datos
William Souter
Chief Financial Officerless than a yearsin datossin datos
Michael Roberts
Head of Investor Relations & Corporate Communications2.9yrssin datossin datos
Fujun Li
Head of Manufacturingless than a yearsin datossin datos
Peter Webse
Company Secretary10.5yrssin datossin datos

2.2yrs

Permanencia media

63yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de ACW se considera experimentado (2.2 años antigüedad media).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Steven Gourlay
MD, CEO & Director3.1yrsAU$656.89k3.94%
A$ 2.9m
Dana Hilt
Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board2.3yrsAU$478.29ksin datos
George Morstyn
Independent Non-Executive Director6.3yrsAU$118.33k0.48%
A$ 359.2k
Geoffrey Edward Brooke
Independent Non-Executive Chairman7.1yrsAU$241.61k0.76%
A$ 565.7k
Colin Masters
Member of Xanamem Clinical Advisory Board9.1yrssin datossin datos
Jeffrey Cummings
Member of Xanamem Clinical Advisory Board9.1yrssin datossin datos
Malcolm McComas
Independent Non-Executive Director5yrsAU$118.33k0.29%
A$ 215.2k
John Harrison
Member of Depression & Cognition Clinical Advisory Board2.3yrssin datossin datos
Craig Ritchie
Chairman of Xanamem Clinical Advisory Board9.1yrssin datossin datos
Jonathan Seckl
Member of Scientific Advisory Boardno datasin datossin datos
Brian Walker
Member of Scientific Advisory Boardno datasin datossin datos
Scott Webster
Member of Scientific Advisory Boardno datasin datossin datos

6.3yrs

Permanencia media

70yo

Promedio de edad

Junta con experiencia: La junta directiva de ACW se considera experimentada (6.3 años de antigüedad promedio).